Home
About Us
Company Profile
Company Culture
Video
Honor
Corporate Style
Products and Solutions
Early Screening
Auxiliary Diagnosis
Interventional Therapy
R & D Center
National Research Team
Qankorey Life International R&D Center
Industry University Research Cooperation
Qualifications and Patents
News
News Center
Industry Information
Image Center
Contact
Talent Recruitment
Business Cooperation
CN
2024-08-13
Innovative early screening for AD, Escort Malaysia's healthy future!
2024-04-01
Qankorey Technology in Malaysia! Foreign Trade Team Visits Kuala Lumpur Hospital Academic Conference
From March 25 to 29, the Qankorey science and technology team went to Kuala Lumpur Hospital in Malaysia to attend an academic conference, during which they had close communication with Dr. Liyana, a professor at Putra Hospital University and head of neurology, Shanthi Visvanathan.
2024-03-28
Pay attention to brain health and guard memory | Qankorey Technology National Alzheimer's disease asymptomatic risk screening public welfare action officially opened
With the increasing aging of the population in China, Alzheimer's disease (AD, commonly known as Alzheimer's disease) has become one of the major diseases that seriously affect the quality of life of the elderly. The Party Central Committee, the State Council and governments at all levels attach great importance to it. In recent years, many policy documents on AD prevention and control have been issued one after another, such as the work plan for exploring the characteristic service of Alzheimer's prevention and control, and the notice on carrying out the promotion action of Alzheimer's prevention and control (2023-2025), which have aroused widespread concern and discussion in the society.
2024-03-18
Qankorey Technology Shines in Mountain City, 2024CACLP Successfully Ends!
As an annual event in the field of in vitro diagnostics, the 2024 China International Laboratory Medicine and Blood Transfusion Instrument and Reagent Expo (CACLP) was held in Chongqing International Expo Center from March 16 to 18. The number of exhibitors exceeded 1300, attracting exhibitors from more than 20 countries and regions and more than 100,000 professional visitors, reflecting the high degree of internationalization, specialization and influence of CACLP as the top event in the IVD industry, it fully demonstrates the vitality and broad prospects of the in vitro diagnostic industry.
2024-03-14
Wu Guiying, member of the Standing Committee of the Provincial Party Committee and Secretary of the Municipal Party Committee, came to Qankorey Science and Technology for investigation and inspection.
On the morning of March 13, Wu Guiying, member of the Standing Committee of the Provincial Party Committee and Secretary of the Municipal Party Committee, investigated the economic and social development in Yuhua District and presided over a symposium, emphasizing the need to anchor the "three highs and four new" beautiful blueprints, study and implement the spirit of the National Two Sessions, and thoroughly implement the eight The general requirements of "walking ahead, making demonstrations" and seven "unswerving" are to build a global R & D center cities, we will further promote the construction of the "Year of Industrial Quality and Efficiency Doubling" and "Year of Good Implementation", improve our position, strengthen our responsibility, innovate and work hard, develop new quality productivity according to local conditions, and promote high-quality development to improve quality and speed up efficiency.
2024-02-29
Qankorey Technology invites | Meet with you at Chongqing International Expo Center
Our company cordially invites you to participate in the 21st China International Laboratory Medicine and Blood Transfusion Instrument and Reagent Expo (CACLP) and the 4th China International IVD Upstream Raw Material Manufacturing and Circulation held at Chongqing International Expo Center from March 16 to 18, 2024. Supply Chain Expo (CISCE)
2024-02-09
Fenji Strive for the First to Go to the Future | Qankorey Technology Wish Everyone a Happy New Year and a Future!!
In 2023, we will have hardships, efforts, touches and gains. The company is of one heart and one mind, working hard, insisting on the key layout of early screening, diagnosis, intervention and treatment of Alzheimer's, persevering and always adhering to independent innovation, with professionalism and responsibility, faith and persistence, and going all out to make a good product.